Skip to main content
. 2015 May 1;10(5):e0124705. doi: 10.1371/journal.pone.0124705

Fig 3. Trx-priming enhances recipients’ spleen CD4+Foxp3+ regulatory cells.

Fig 3

Panels A, B and C shows representative images of one of three separate flow cytometric analysis of spleen CD4 and Foxp3 intracellular staining on day 5, 21 and 37 post-transplant recipients, respectively. Panel D shows quantitatively analysis of host spleen Foxp3+ CD4+ T cells. Data represent mean ± SE, n = 3.*p<0.05 vs Trx (-).